Rochester, Minnesota 55905

  • Stoma

Purpose:

This investigation constitutes an initial evaluation of the stoma occlusion device in humans with a mature permanent Brooke ileostomy. The overall objective of this study is to assess feasibility and initial operating characteristics of a novel stoma occlusion device. The study will recruit 20 patients for placement of the device into the mature Brooke ileostomy and subsequent 2 hour observation period. The device will remain in the ileostomy for up to 2 hours.


Study summary:

An ostomy is a protrusion of part of the intestines extending through the abdominal wall for the purpose of elimination of wastes and may be temporary or permanent depending on the purpose of the initial surgery. The most common reasons for permanent bowel diversion are cancer and ulcerative colitis. Appliances have improved greatly over the last 50 years, but patients continue to experience appliance leakage and skin infections and struggle with the emotional and social impact of an external pouch. This study seeks to answer the opportunity to significantly improve quality of life to a large segment of the global population through optimization of a technology for a stoma occlusion device in patients with permanent stomas. Four pre-clinical animal studies have been conducted. All the animals that completed the study tolerated the device well and had no adverse reactions to device materials. This project will allow a prototype of an artificial stomal occlusion device to be tested in humans.


Criteria:

Inclusion Criteria: - Age range: 18 and older - Gender: Male and Female - Target disease or condition: 20 patients with permanent End Ileostomy, specifically Brooke ileostomy for greater than 3 years - Ability to comply with protocol - Competent and able to provide written informed consent Exclusion Criteria: - Inability to provide consent - Crohn's Disease - Koch pouch - Pregnancy - If subject's stoma length is less than 4 cm or longer than 8 cm - Clinically significant medical conditions within the six months before participation with the device that would, in the opinion of the investigators, compromise the safety of the patient.


NCT ID:

NCT03549780


Primary Contact:

Principal Investigator
William A Faubion, M.D.
Mayo Clinic

Jessica Friton
Phone: 507-284-0495
Email: friton.jessica@mayo.edu


Backup Contact:

N/A


Location Contact:

Rochester, Minnesota 55905
United States

Jessica Friton
Phone: 507-284-0495
Email: friton.jessica@mayo.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: June 21, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.